Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Business Wire
Castor Appoints New CFO to Drive Transformative Growth
June 26, 2023 -
PR Newswire
Innovent and RemeGen Enter into Clinical Trial Collaboration Investigating Combination Therapy of TYVYT® (sintilimab injection) and Novel ADC Candidates for Advanced Solid Tumors in China
June 25, 2023 -
Time
TIME100 Most Influential Companies 2023: Equip
June 22, 2023 -
Business Wire
Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023
June 22, 2023 -
BioCentury
ARTBIO: manufacturing strategy to lead on lead-212 radiotherapies
June 22, 2023 -
Endpoints News
Ultragenyx opens new gene therapy manufacturing site in Massachusetts
June 21, 2023 -
PR Newswire
ARTBIO Launches to Develop New Class of Alpha Radioligand Therapies Designed to Maximize Therapeutic Potential
June 21, 2023 -
Endpoints News
ARTBIO emerges with $23M to make radioligand therapies for prostate cancer, with field still in ‘early days’
June 21, 2023 -
Home Health Care News
WelbeHealth’s Michael Le On The Future Of Innovative At-Home Care Models
June 20, 2023 -
PR Newswire
Silver Cross Hospital Expands Use of Kyruus’ Award-Winning Online Scheduling Solution Across Specialties and Services
June 20, 2023 -
Endpoints News
India’s Enzene Biosciences unveils $50M New Jersey plant project, plans to hire 300
June 20, 2023 -
Globenewswire
Equip Names Nikia Bergan as the Company’s First President
June 20, 2023 -
Fierce Healthcare
Equip taps healthcare exec Nikia Bergan as new president to scale up virtual eating disorder treatment services
June 20, 2023 -
Globenewswire
Denali Therapeutics Announces Robust Reduction in Neurofilament Light (NfL) with DNL310 (ETV:IDS) Treatment in MPS II (Hunter Syndrome)
June 20, 2023 -
Globenewswire
NodThera announces positive first-in-human data for two brain penetrant NLRP3 inflammasome inhibitors
June 20, 2023 -
News Direct
Doceree launches industry-first HCP-focused global DSP for media agencies at Cannes Lions 2023
June 19, 2023 -
GenomeWeb
With $50M Investment in MOSAIC Project, Owkin Seeks to Become Cancer ‘Drug Discovery Enterprise’
June 16, 2023 -
Eleos Health
Eleos Health Partners with Trilogy, Adds COO to Customer Advisory Board
June 14, 2023 -
Accesswire
Owkin Rolls Out Its Landmark AI Diagnostic Within Medipath, the Largest Network of Pathologists in France
June 14, 2023 -
Business Wire
Wedgewood Pharmacy Merges with Blue Rabbit to Deliver Exceptional Veterinary Pharmacy Services Nationwide
June 14, 2023 -
Behavioral Health Business
BHB Value: The Pursuit of High Quality Applied Behavior Analysis
June 13, 2023 -
PR Newswire
Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor
June 13, 2023 -
Drug Target Review
Game-changing pan-TEAD inhibitor for solid tumours
June 12, 2023 -
Business Insider
The fertility business is booming as startups go after big profits in a $54 billion market, even as other healthcare companies slump
June 12, 2023 -
Globenewswire
Pulmocide Announces Expansion of Management Team
June 8, 2023 -
PR Newswire
Equip Partnership Adds Eating Disorder Support to Accolade’s Trusted Partner Ecosystem
June 7, 2023 -
USA Today
Pregnant and over 40? You aren’t alone. More women are becoming later-in-life moms.
June 7, 2023 -
PR Newswire
Benchling Delivers an Integrated R&D Ecosystem with New Product Offerings
June 6, 2023 -
Endpoints News
Early data show Bicara’s bispecific helps shrink head and neck cancers when combined with Keytruda: #ASCO23
June 5, 2023 -
Business Wire
Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β Inhibitor, BCA101, Demonstrates 65% ORR in Combination with Pembrolizumab in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
June 5, 2023 -
BioWorld
Insilico Medicine describes new USP1 inhibitors for cancer
June 2, 2023 -
Boston Business Journal
Long-term optimism, but short-term worry among Mass. biotech VCs
June 2, 2023 -
Pharmabiz
PlasmaGen Biosciences to invest in Karnataka for advanced blood plasma production unit
June 2, 2023 -
PR Newswire
WelbeHealth Continues Los Angeles Expansion With Opening of New PACE Centers in Rosemead and North Hollywood
June 1, 2023 -
BioWorld
Insilico Medicine divulges new 3CLpro inhibitors for SARS-CoV-2
June 1, 2023 -
PR Newswire
TraceLink Ensures DSCSA Verification Readiness and End-to-End VRS Support for Pharmaceutical Supply Chain Members Amid Vendor Turbulence
June 1, 2023 -
Business Wire
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
June 1, 2023 -
Pharmabiz
Lupin collaborates with Enzene Biosciences to launch Cetuximab in India to treat head and neck cancer
May 30, 2023 -
PR Newswire
PlasmaGen Biosciences opens new manufacturing facility for blood plasma products in Kolar
May 30, 2023 -
PR Newswire
ABK Biomedical Announces FDA IDE Approval for a Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma
May 30, 2023 -
Newswire
Protenus Selected as One of the 2023 Best Places to Work in Healthcare
May 30, 2023 -
Financial Express
Enzene Biosciences launches first biosimilar of Cancer treatment drug Erbitux
May 29, 2023 -
Globenewswire
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity
May 25, 2023 -
Business Wire
BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
May 25, 2023 -
Accesswire
Protenus Granted New Patent for Drug Diversion Surveillance Technology
May 24, 2023 -
PR Newswire
FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis
May 22, 2023 -
Endpoints News
Comanche lines up trial for preeclampsia siRNA with Moderna, Medicines Company vets and GV backing
May 19, 2023 -
Globenewswire
Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT
May 19, 2023 -
PR Newswire
Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
May 17, 2023 -
PR Newswire
Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy
May 17, 2023 -
News 12 - New Jersey
be Well: Howie Mandel talks about his OCD diagnosis and what led him to seek help
May 16, 2023 -
Newswire
Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis
May 16, 2023 -
Business Wire
Ensoma Closes Series B Extension, Bringing Total Round to $135 Million
May 16, 2023 -
Globenewswire
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023 -
Business Wire
CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA
May 15, 2023 -
PR Newswire
Rippl Appoints Industry Leading CEOs to Board Bringing Significant New Experience in Tech-enabled, Value-based Services and Senior-focused Mental and Behavioral Health
May 15, 2023 -
PR Newswire
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma
May 14, 2023 -
PR Newswire
Comanche Biopharma Appoints Allyson Felix to Board of Directors
May 12, 2023 -
Globenewswire
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
May 12, 2023 -
Globenewswire
Avalyn Pharma Showcasing Therapeutic Approach and Clinical Status at ATS 2023 and the Respiratory Innovation Summit (RIS)
May 11, 2023 -
PR Newswire
Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint
May 10, 2023 -
Globenewswire
AI Drug Discovery Company Insilico Medicine Offers Free Course on Target Identification
May 10, 2023 -
PR Newswire
Doceree forms an exclusive partnership with Hello Health Group to strengthen its global footprint; forays into 8 South East Asian markets
May 10, 2023 -
Fierce Pharma
The most influential people in biopharma in 2023
May 9, 2023 -
Labiotech
Generative AI in novel drug development
May 2, 2023 -
Fierce Healthcare
Eleos Outreach brings AI-enabled click-to-text functionality to field-based clinicians’ EHRs
May 1, 2023 -
Fox News
Students use AI technology to find new brain tumor therapy targets — with a goal of fighting disease faster
May 1, 2023 -
Business Wire
Bicara Therapeutics Announces Oral Presentation of Head and Neck Cancer Dose Expansion Data from Phase 1/1b Study of BCA101 at Upcoming 2023 ASCO Annual Meeting
April 27, 2023 -
PR Newswire
Eleos Advances Behavioral Health AI with Breakthrough Offering for Field Providers
April 27, 2023 -
Globenewswire
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
April 24, 2023 -
Fierce Biotech
AppliedVR’s latest partnership expands covered access to VR therapeutics for veterans, active military
April 24, 2023 -
Business Wire
Bicara Therapeutics Announces Publication in Cancer Research Describing Design and Characterization of Lead Bifunctional Antibody Program, BCA101
April 19, 2023 -
Business Wire
Leyden Labs’ Intranasal PanFlu Antibody Enters the Clinic
April 19, 2023 -
PR Newswire
First-of-its-kind “Global Fertility at Work” Report from Carrot Fertility Reveals Financial Burden and Workplace Stigma are the Biggest Roadblocks to Accessing Fertility and Family-Forming Care
April 18, 2023 -
BBC News Services
How artificial intelligence is matching drugs to patients
April 17, 2023 -
BioPharma Dive
Biogen, aiming for a better Alzheimer’s therapy, licenses a Denali program
April 13, 2023 -
Globenewswire
Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses
April 13, 2023 -
Business Wire
Health Data Cloud Leader 1upHealth Raises $40 Million Series C led by Sixth Street Growth
April 13, 2023 -
Globenewswire
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
April 12, 2023 -
PR Newswire
AppliedVR Partners with Lovell to Better Serve Government Healthcare Systems
April 12, 2023 -
Business Insider
Devoted Health narrowed its losses in 2022, as rival insurance upstarts fought for survival. Now it’s adding members amid a big expansion.
April 11, 2023 -
Business Wire
Firefly Health Launches Advisory Council to Support Business Growth and Product Expansion
April 11, 2023 -
Business Wire
Rallybio Announces Clinical Proof-of-Concept Results for RLYB211, an Anti-HPA-1a Polyclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), Published in the Journal of Thrombosis and Haemostasis
April 6, 2023 -
Business Wire
Bicara Therapeutics to Present Preclinical Data from Clinical-Stage Bifunctional Antibody Program, BCA101, at AACR Annual Meeting 2023
April 4, 2023 -
Authority Magazine
Health Tech: Jake Sattelmair Of Wellframe On How Their Technology Can Make An Important Impact On Our Overall Wellness
April 2, 2023 -
tech.eu
French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment
March 31, 2023 -
Owkin
Owkin launches PortrAIt – a €33 million project to make France a global leader in using AI to diagnose and treat diseases
March 31, 2023 -
Home Health Care News
How Primary Care Startup Patina Locked Down Partnerships With 4 Big Health Plans
March 30, 2023 -
PR Newswire
Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia
March 30, 2023 -
Fierce Healthcare
Carrot Fertility expands benefits with hormone replacement therapy coverage
March 29, 2023
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.